Esperion Therapeutics Stock Chart Offers Silver Lining as Shares Dip

Aptose Biosciences scored a licensing deal with OHM Oncology

Managing Editor
Mar 7, 2018 at 10:12 AM
facebook X logo linkedin


Drugmakers Aptose Biosciences Inc (NASDAQ:APTO) and Esperion Therapeutics Inc (NASDAQ:ESPR) are both making headlines this morning, but for different reasons. We'll dig into APTO and ESPR stocks below.

Aptose Biosciences Scores Deal With OHM Oncology

Aptose Biosciences stock is up 1.9% to trade at $3.24, after the company announced a global license deal with OHM Oncology to develop and commercialize a cancer drug. Aptose could make up to $125 million depending on the success of the deal. APTO stock has been a steady riser of the past year, adding 183% and touching a two-year high of $3.90 on Jan. 24. Not many analysts have taken notice of this outperformance, however, as just two brokerage firms are currently tracking APTO.

Esperion Stock Falls Despite Upbeat Cholesterol Drug Data

Esperion stock is down 3% to trade at $75.62, despite the news that the company's oral cholesterol drug met its late-stage trial goals. Still, ESPR shares are up 136% year-over-year, and touched a two-year high of $82.68 last Tuesday. The 50-day moving average is providing support today, too, as it did during pullbacks in December and February.

In the options pits, puts have never been more popular this year relative to calls. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security sports a 10-day put/call volume ratio of 3.78, which ranks in the 100th percentile of its annual range.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI